| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |